Jasper Therapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update

May 13, 2023

https://www.globenewswire.com/news-release/2023/05/12/2668154/0/en/Jasper-Therapeutics-Reports-First-Quarter-2023-Financial-Results-and-Provides-a-Business-Update.html

REDWOOD CITY, Calif., May 12, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq:JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, today announced results for the fiscal quarter ended March 31, 2023, and provided a business update.

Read more at globenewswire.com

Related news for (JSPR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.